Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Ursula CreutzigMichael N DworzakMartin ZimmermannDirk ReinhardtLucie SramkovaJan Pierre BourquinHenrik HasleJonas AbrahamssonGertjan KaspersMary M van den HeuvelArdine M J ReedijkBarbara De MoerlooseFranco LocatelliRiccardo MasettiPublished in: Pediatric blood & cancer (2017)
Although CNS relapses occurred more frequently in initially CNS-positive patients, their global outcome was similar as in CNS-negative patients. Intensified IT therapy was heterogeneous; however, at least eight applications, preferably with triple IT chemotherapy, seem to be appropriate to accompany dose-intensive systemic chemotherapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- acute myeloid leukemia
- ejection fraction
- blood brain barrier
- peritoneal dialysis
- squamous cell carcinoma
- stem cells
- patient reported outcomes
- locally advanced
- mesenchymal stem cells
- acute lymphoblastic leukemia
- bone marrow
- allogeneic hematopoietic stem cell transplantation